MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$316,583
Cash
$251,291
Total current assets
$567,874
Operating lease
right-of-use asset
$126,628
Equipment and
furnishings, less...
$3,000
Accumulated deficit
-$262,853,812
Accumulated other
comprehensive loss
-$60,191
Total assets
$697,502
Total provectus
biopharmaceuticals, inc.,...
-$6,298,737
Non-controlling interest in
subsidiary
-$3,981
Additional paid-in capital
$256,179,846
Common stock par value
0.001 per share...
$420,280
Preferred stock,
value-Series DOne...
$14,183
Preferred stock,
value-Series DConvertible...
$957
Total liabilities and
stockholders deficit
$697,502
Total stockholders
deficit
-$6,302,718
Total liabilities
$7,000,220
Total current
liabilities
$6,897,378
Operating lease
liability, non-current...
$79,221
Notes payable,
non-current portion
$23,621
Other accrued
expenses
$3,161,379
Convertible notes
payable-Related Party
$1,740,000
Convertible notes
payable-Nonrelated Party
$870,000
Accounts payable
$716,220
Notes payable
$217,772
Accrued
interest-Related Party
$120,384
Operating lease
liability, current portion
$48,083
Accrued
interest-Nonrelated Party
$23,540
Back
Back
Balance Sheet
source: myfinsight.com
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)